Biohaven Pharmaceutical Ltd. (NYSE: BHVN) released preliminary second-quarter revenue data for its drug Nurtec ODT on Wednesday.
What Happened: Nurtec achieved preliminary net product revenue of approximately $93 million in the second quarter, according to the company.
Torchlight Energy Resources Inc (NASDAQ: TRCH) is trading significantly higher Monday morning after the company provided an update on its proposed business combination with Metamaterial Inc (OTC: MMATF).